Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Pepgen
company
About
Pepgen is a privately-held biopharmaceutical company that develops novel products for the treatment of autoimmune and viral disorders.
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $7.50M
- Industries
- Biopharma,Medical,Pharmaceutical
- Founded date
- Jan 1, 1992
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pepgen is a privately-held biopharmaceutical company that develops and commercializes novel products for the prevention and treatment of autoimmune and viral disorders.
It was founded in 1992 by Chih-Ping Liu and is based in Alameda, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$7.50M
Pepgen has raised a total of
$7.50M
in funding over 2 rounds. Their latest funding was raised on
Aug 3, 2004 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 3, 2004 | Series D | $7.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Pepgen is funded by 2 investors.
Biotechnology Development Fund VI, L.P.
and Veron International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
